Literature DB >> 4627625

Some hypotheses concerning the functional organization of prefrontal cortex.

J Konorski.   

Abstract

The paper deals with systematization of the behavioral disorders after partial prefrontal lesions. It is assumed that depending on the localization of lesions two disorders may be discerned: impairment of drive inhibition (meaning by this only preservative but not protective drives) land of motor-act inhibition. The first deficit leads to the disinhibition of no-go responses in Pavlovian differentiation, the second one to the disorder of R1-R2 differentiation due to the difficulty of switching from one response to the other. Different parts of the prefrontal cortex are engaged in directional response and nondirectional response differentiation. It is posltulated that drive inhibition depends on the limbo-prefrontal system, whereas motor-act inhibition depends on the premotor-prefrontal system for manipulatory responses and the caudate-prefrontal system for locomotor responses.

Entities:  

Mesh:

Year:  1972        PMID: 4627625

Source DB:  PubMed          Journal:  Acta Neurobiol Exp (Wars)        ISSN: 0065-1400            Impact factor:   1.579


  4 in total

Review 1.  The signal attenuation rat model of obsessive-compulsive disorder: a review.

Authors:  Daphna Joel
Journal:  Psychopharmacology (Berl)       Date:  2006-07       Impact factor: 4.530

2.  The effects of the quality and probability of reinforcement on feeder selection by lobectomized dogs.

Authors:  L A Preobrazhenskaya; M E Ioffe; V N Mats
Journal:  Neurosci Behav Physiol       Date:  2005-06

3.  Scopolamine and acquisition of go-no go avoidance: a further analysis of the perseverative antimuscarinic deficit.

Authors:  V Giardini; L Amorico; L De Acetis; G Bignami
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

4.  Influence of housing conditions and state of partner on conditioning and extinction of taste aversion to lithium and chlorpromazine.

Authors:  V Giardini
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.